GRI Bio, Inc. (GRI) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$1.81
—
Mkt Cap $174.27K
EPS — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 13, 2026 | — | — | — | -$29.27 | -$13.25 | +54.73% |
| Q4 2025 Nov 14, 2025 | — | $6.33M | — | -$31.09 | -$35.85 | -15.31% |
| Q3 2025 Aug 14, 2025 | — | $22.54M | — | -$1.31 | -$1.31 | +0.00% |
| Q2 2025 May 15, 2025 | — | — | — | -$4.11 | -$5.80 | -41.12% |
| Q4 2024 Dec 16, 2024 | — | — | — | — | -$319.73 | — |
| Q4 2024 Nov 14, 2024 | — | — | — | -$0.73 | -$11.39 | -1460.27% |
| Q3 2024 Aug 13, 2024 | — | — | — | — | -$83.67 | — |
| Q2 2024 May 10, 2024 | — | — | — | — | -$101.73 | — |
| Q3 2023 Aug 14, 2023 | — | — | — | — | -$4317.86 | — |
| Q2 2023 May 15, 2023 | — | — | — | — | -$8248.81 | — |
| Q1 2023 Feb 24, 2023 | — | — | — | -$13458.90 | -$0.10 | +100.00% |
| Q4 2022 Dec 31, 2022 | — | — | — | — | -$1286.28 | — |
| Q3 2022 Sep 30, 2022 | — | — | — | -$11602.50 | -$221.59 | +98.09% |
| Q2 2022 Jun 30, 2022 | — | — | — | -$10674.30 | -$259.68 | +97.57% |
| Q1 2022 Mar 31, 2022 | — | — | — | -$46.20 | -$2957.35 | -6301.19% |
| Q4 2021 Dec 31, 2021 | — | — | — | — | -$3474.75 | — |
| Q3 2021 Sep 30, 2021 | — | — | — | — | -$1410.77 | — |
| Q2 2021 Jun 30, 2021 | — | — | — | — | -$2594.84 | — |
| Q1 2021 Mar 31, 2021 | — | — | — | — | -$2960.72 | — |
| Q4 2020 Dec 31, 2020 | — | — | — | — | -$1648.71 | — |
| Q3 2020 Sep 30, 2020 | — | — | — | — | -$1172.84 | — |
| Q2 2020 Jun 30, 2020 | — | — | — | — | -$1287.32 | — |
| Q1 2020 Mar 31, 2020 | — | $100.00K | — | — | -$1303.03 | — |
| Q4 2019 Dec 31, 2019 | — | — | — | — | -$978.11 | — |
| Q3 2019 Sep 30, 2019 | — | — | — | — | -$1065.10 | — |
| Q2 2019 Jun 30, 2019 | — | — | — | — | -$1084.18 | — |
| Q1 2019 Mar 31, 2019 | — | — | — | — | -$760.94 | — |